0 01/08/2024 31/07/2025 2025-07-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2024-08-01 Sage Accounts Production 25.0 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 15038059 2024-08-01 2025-07-31 15038059 2025-07-31 15038059 2024-07-31 15038059 2023-08-01 2024-07-31 15038059 2024-07-31 15038059 2023-07-31 15038059 bus:RegisteredOffice 2024-08-01 2025-07-31 15038059 bus:LeadAgentIfApplicable 2024-08-01 2025-07-31 15038059 bus:Director1 2024-08-01 2025-07-31 15038059 core:WithinOneYear 2025-07-31 15038059 core:WithinOneYear 2024-07-31 15038059 bus:Micro-entities 2024-08-01 2025-07-31 15038059 bus:AuditExempt-NoAccountantsReport 2024-08-01 2025-07-31 15038059 bus:SmallCompaniesRegimeForAccounts 2024-08-01 2025-07-31 15038059 bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 15038059 bus:FullAccounts 2024-08-01 2025-07-31
Company registration number: 15038059
Clinical-Ink Limited
Unaudited filleted financial statements
31 July 2025
Clinical-Ink Limited
Contents
Directors and other information
Statement of financial position and notes to the financial statements
Clinical-Ink Limited
Directors and other information

| Director | Keely Sutton
| Company number | 15038059
| Registered office | 23 Ridleys Close
|  | Countesthorpe
|  | Leicester
|  | LE8 5AG
| Business address | 23 Ridleys Close
|  | Countesthorpe
|  | Leicester
|  | LE8 5AG
| Accountants | SL Accountants
|  | 22 Almond Road
|  | Lubbesthorpe
|  | LE19 4LD

Clinical-Ink Limited
Statement of financial position
31 July 2025

|  |  | 2025 |  | 2024 |  |
|  |  | £ |  | £ |  |
Current assets |  |  | 972 |  | 3,108 |  |
Creditors: amounts falling due within one year |  |  | ( 749) |  | ( 1,042) |  |
|  |  | _______ |  | _______ |  |
Net current assets |  |  | 223 |  | 2,066 |  |
|  |  | _______ |  | _______ |  |
Total assets less current liabilities |  |  | 223 |  | 2,066 |  |
|  |  | _______ |  | _______ |  |
Net assets |  |  | 223 |  | 2,066 |  |
|  |  | _______ |  | _______ |  |
Capital and reserves |  |  | 223 |  | 2,066 |  |
|  |  | _______ |  | _______ |  |

Clinical-Ink Limited
Year ended 31 July 2025
Notes to the financial statements
1. Directors advances, credits and guarantees
For the year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The member has not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 06 October 2025 , and are signed on behalf of the board by:
Keely Sutton
Director
Company registration number: 15038059
The company is a private company limited by shares, registered in England & Wales.